Oral Proteins and Peptides Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 538027
  • Pages : 95
  • Published On : Dec 2020
  • Industry : Medical Devices
  • Format :

Choose License Type

Single User License: US$ 3,000
Multi User License: US$ 6,000
Corporate User License: US$ 6,000
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Oral Proteins and Peptides market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Oral Proteins and Peptides are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Oral Proteins and Peptides market segmented into
Linaclotide 
Plecanatide 
Octreolin

Based on the end-use, the global Oral Proteins and Peptides market classified into
Medicine 
Healthcare 

Based on geography, the global Oral Proteins and Peptides market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
ZydusCadilla Healthcare 
Sanofi-Aventis LLC 
Roche, Inc. 
Pfizer, Inc. 
Novartis AG 
Johnson & Johnson 
Abbott Laboratories 
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ORAL PROTEINS AND PEPTIDES INDUSTRY
2.1 Summary about Oral Proteins and Peptides Industry
2.2 Oral Proteins and Peptides Market Trends
2.2.1 Oral Proteins and Peptides Production & Consumption Trends
2.2.2 Oral Proteins and Peptides Demand Structure Trends
2.3 Oral Proteins and Peptides Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Linaclotide
4.2.2 Plecanatide
4.2.3 Octreolin
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Medicine
4.3.2 Healthcare
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Linaclotide
5.2.2 Plecanatide
5.2.3 Octreolin
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Medicine
5.3.2 Healthcare
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Linaclotide
6.2.2 Plecanatide
6.2.3 Octreolin
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Medicine
6.3.2 Healthcare
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Linaclotide
7.2.2 Plecanatide
7.2.3 Octreolin
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Medicine
7.3.2 Healthcare
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Linaclotide
8.2.2 Plecanatide
8.2.3 Octreolin
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Medicine
8.3.2 Healthcare
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Linaclotide
9.2.2 Plecanatide
9.2.3 Octreolin
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Medicine
9.3.2 Healthcare
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 ZydusCadilla Healthcare
10.1.2 Sanofi-Aventis LLC
10.1.3 Roche, Inc.
10.1.4 Pfizer, Inc.
10.1.5 Novartis AG
10.1.6 Johnson & Johnson
10.1.7 Abbott Laboratories
10.2 Oral Proteins and Peptides Sales Date of Major Players (2017-2020e)
10.2.1 ZydusCadilla Healthcare
10.2.2 Sanofi-Aventis LLC
10.2.3 Roche, Inc.
10.2.4 Pfizer, Inc.
10.2.5 Novartis AG
10.2.6 Johnson & Johnson
10.2.7 Abbott Laboratories
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
Table Oral Proteins and Peptides Product Type Overview
Table Oral Proteins and Peptides Product Type Market Share List
Table Oral Proteins and Peptides Product Type of Major Players
Table Brief Introduction of ZydusCadilla Healthcare
Table Brief Introduction of Sanofi-Aventis LLC
Table Brief Introduction of Roche, Inc.
Table Brief Introduction of Pfizer, Inc.
Table Brief Introduction of Novartis AG
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Abbott Laboratories
Table Products & Services of ZydusCadilla Healthcare
Table Products & Services of Sanofi-Aventis LLC
Table Products & Services of Roche, Inc.
Table Products & Services of Pfizer, Inc.
Table Products & Services of Novartis AG
Table Products & Services of Johnson & Johnson
Table Products & Services of Abbott Laboratories
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Oral Proteins and Peptides Market Forecast (Million USD) by Region 2021f-2026f
Table Global Oral Proteins and Peptides Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Oral Proteins and Peptides Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Oral Proteins and Peptides Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
Figure Global Oral Proteins and Peptides Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Proteins and Peptides Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Proteins and Peptides Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Proteins and Peptides Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oral Proteins and Peptides Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oral Proteins and Peptides Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oral Proteins and Peptides Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plecanatide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Octreolin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Healthcare Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of ZydusCadilla Healthcare 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Sanofi-Aventis LLC 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Roche, Inc. 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Pfizer, Inc. 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Oral Proteins and Peptides Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...

Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...

Global Sleep Apnea Oral Appliances Market Report- Global Strategic Analysis, Size, Share, Trend, and Forecast (2023-2030)...

This report gives an insight into the global Sleep Apnea Oral Appliances Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall ...

Global Genetically Enhanced Bacterial Proteins Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Genetically Enhanced Bacterial Proteins Market: The report discusses everything a marketer requires before investing in the global Genetically Enhanced Bacterial Proteins Market during the for...

Global Biotechnologically Altered Bacterial Proteins Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Biotechnologically Altered Bacterial Proteins Market: The report discusses everything a marketer requires before investing in the global Biotechnologically Altered Bacterial Proteins Market du...

Global Modified Genetically Engineered Bacterial Proteins Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Modified Genetically Engineered Bacterial Proteins Market: The report discusses everything a marketer requires before investing in the global Modified Genetically Engineered Bacterial Proteins...

Global Genetically Modified Bacterial Proteins Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Genetically Modified Bacterial Proteins Market: The report discusses everything a marketer requires before investing in the global Genetically Modified Bacterial Proteins Market during the for...

Global Potassium Chloride Oral Solution Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Potassium Chloride Oral Solution Market: The report discusses everything a marketer requires before investing in the global Potassium Chloride Oral Solution Market during the forecast period 2...